Regulation of mitotic exit by the RNF8 ubiquitin ligase.

Abstract:

:RNF8 is a ubiquitin ligase with a FHA domain near its N terminus, and a RING-finger domain at its C terminus, through which it recruits several ubiquitin-conjugating enzymes. In metazoans, only the mitotic checkpoint regulator CHFR shares this domain architecture. Here we show that RNF8 is a nuclear protein that follows a cell-cycle-dependent turnover, reaching its highest levels in mitosis, followed by a strong decline in late mitotic stages. Overexpression of RNF8 caused a delay in cytokinesis and the frequent appearance of aberrant mitotic figures. These effects were dependent on the ubiquitin ligase activity of RNF8, since they were significantly attenuated when a RING-finger mutant, inactive as an E3, was overexpressed. Depletion of RNF8 also caused a delay in the exit from the mitotic arrest induced by nocodazole, associated with a reduced turnover of the APC/C substrate cyclin B1. These observations suggest that RNF8 regulates the rate of exit from mitosis and cytokinesis.

journal_name

Oncogene

journal_title

Oncogene

authors

Plans V,Guerra-Rebollo M,Thomson TM

doi

10.1038/sj.onc.1210782

subject

Has Abstract

pub_date

2008-02-28 00:00:00

pages

1355-65

issue

10

eissn

0950-9232

issn

1476-5594

pii

1210782

journal_volume

27

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Serine/threonine phosphatases in the DNA damage response and cancer.

    abstract::The cellular response to DNA damage is a crucial surveillance mechanism that maintains genomic integrity and prevents cancer progression. Previous studies identified multiple Ser/Thr protein kinases that have pivotal roles in the activation of this response. It is interesting that a growing body of evidence suggests t...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2010.371

    authors: Peng A,Maller JL

    更新日期:2010-11-11 00:00:00

  • Chemosensitization of HER-2/neu-overexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 E1A.

    abstract::Breast cancer cells that overexpress HER-2/neu are more resistant to chemotherapeutic agents such as paclitaxel (Taxol) and docetaxel (Taxotere) than those that do not overexpress HER-2/neu. In previous work, we showed that the adenovirus type 5 E1A can repress HER-2/neu expression at the transcriptional level. Here w...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201250

    authors: Ueno NT,Yu D,Hung MC

    更新日期:1997-08-18 00:00:00

  • Identification of novel VHL targets that are associated with the development of renal cell carcinoma.

    abstract::von Hippel-Lindau (VHL) disease is a dominantly inherited family cancer syndrome characterized by the development of retinal and central nervous system haemangioblastomas, renal cell carcinoma (RCC) and phaeochromocytoma. Specific germline VHL mutations may predispose to haemangioblastomas, RCC and phaeochromocytoma t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209932

    authors: Abdulrahman M,Maina EN,Morris MR,Zatyka M,Raval RR,Banks RE,Wiesener MS,Richards FM,Johnson CM,Latif F,Maher ER

    更新日期:2007-03-08 00:00:00

  • The adenovirus E1A domains required for induction of DNA rereplication in G2/M arrested cells coincide with those required for apoptosis.

    abstract::Induction of apoptosis by adenovirus E1A in rodent cells is stimulated by wild type (wt) p53 but completely suppressed by mutated p53. The suppression is overcome by coexpression with Id proteins (Ids). The cells expressing E1A and Ids undergo apoptosis after accumulation in S phase, suggesting that S phase events are...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203063

    authors: Yageta M,Tsunoda H,Yamanaka T,Nakajima T,Tomooka Y,Tsuchida N,Oda K

    更新日期:1999-08-26 00:00:00

  • Src family kinases mediate cytoplasmic retention of activated STAT5 in BCR-ABL-positive cells.

    abstract::Persistent activation of the Abl tyrosine kinase in the BCR-ABL fusion protein is the major cause of chronic myeloid leukemia (CML). Among many other substrates BCR-ABL phosphorylates STAT5 and Src family kinases (SFK). Activated pSTAT5 is essential for initial transformation and maintenance of the disease. Cytokine-i...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.369

    authors: Chatain N,Ziegler P,Fahrenkamp D,Jost E,Moriggl R,Schmitz-Van de Leur H,Müller-Newen G

    更新日期:2013-08-01 00:00:00

  • Cyclin D3 action in androgen receptor regulation and prostate cancer.

    abstract::Prostate cancer (PCa) cell proliferation is dependent on activation of the androgen receptor (AR), a ligand-dependent transcription factor. AR activation controls G1-S phase progression through fostering enhanced translation of the D-type cyclins, which promote cell cycle progression through activation of CDK4/6. Howe...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210981

    authors: Olshavsky NA,Groh EM,Comstock CE,Morey LM,Wang Y,Revelo MP,Burd C,Meller J,Knudsen KE

    更新日期:2008-05-15 00:00:00

  • Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2.

    abstract::Emerging evidence has shown that cancer stem cells (CSCs) are the cellular determinants to promote cancer invasion and metastasis. However, the mechanism underlying CSC invasion remains unknown. MicroRNAs are evolutionally conserved small noncoding RNAs that are critical for the regulation of gene expression, and thei...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.75

    authors: Wang Z,Wang B,Shi Y,Xu C,Xiao HL,Ma LN,Xu SL,Yang L,Wang QL,Dang WQ,Cui W,Yu SC,Ping YF,Cui YH,Kung HF,Qian C,Zhang X,Bian XW

    更新日期:2015-03-12 00:00:00

  • Prolyl isomerase Pin1 stabilizes and activates orphan nuclear receptor TR3 to promote mitogenesis.

    abstract::Pin1 regulates a subset of phosphoproteins by isomerizing phospho-Ser/Thr-Pro motifs via a 'post-phosphorylation' mechanism. Here, we characterize TR3 as a novel Pin1 substrate, and the mitogenic function of TR3 depends on Pin1-induced isomerization. There are at least three phospho-Ser-Pro motifs on TR3 that bind to ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.463

    authors: Chen HZ,Li L,Wang WJ,Du XD,Wen Q,He JP,Zhao BX,Li GD,Zhou W,Xia Y,Yang QY,Hew CL,Liou YC,Wu Q

    更新日期:2012-06-07 00:00:00

  • Role of p14ARF-HDM2-p53 axis in SOX6-mediated tumor suppression.

    abstract::Sex-determining region Y box 6 (SOX6) has been described as a tumor-suppressor gene in several cancers. Our previous work has suggested that SOX6 upregulated p21(Waf1/Cip1)(p21) expression in a p53-dependent manner; however, the underlying mechanism has remained elusive. In this study, we confirmed that SOX6 can suppr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.234

    authors: Wang J,Ding S,Duan Z,Xie Q,Zhang T,Zhang X,Wang Y,Chen X,Zhuang H,Lu F

    更新日期:2016-03-31 00:00:00

  • c-Jun causes focus formation and anchorage-independent growth in culture but is non-tumorigenic.

    abstract::The RCAS retroviral vector was used to express chicken and mouse cellular Jun proteins in chicken embryo fibroblasts. Both mouse and chicken proteins induced foci of transformed cells with low to moderate efficiency compared with viral Jun, but were as effective as the viral protein in promoting anchorage-independent ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Wong WY,Håvarstein LS,Morgan IM,Vogt PK

    更新日期:1992-10-01 00:00:00

  • Genetic programs regulating HSC specification, maintenance and expansion.

    abstract::All mature blood cells originate from a small population of self-renewing pluripotent hematopoietic stem cells (HSCs). The capacity to self-renew characterizes all stem cells, whether normal or neoplastic. Interestingly, recent studies suggest that self-renewal is essential for tumor cell maintenance, implicating that...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1207940

    authors: Lessard J,Faubert A,Sauvageau G

    更新日期:2004-09-20 00:00:00

  • siRNA screening identifies differences in the Fanconi anemia pathway in BALB/c-Trp53+/- with susceptibility versus C57BL/6-Trp53+/- mice with resistance to mammary tumors.

    abstract::BALB/c mice heterozygous for Trp53 develop a high proportion of spontaneous mammary tumors, a phenotype distinct from other mouse strains. BALB/c-Trp53+/- female mice, thus, resemble the hereditary Li-Fraumeni syndrome (LFS) characterized by early-onset of breast cancer, even though LFS involves TP53 mutations, which ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.38

    authors: Böhringer M,Obermeier K,Griner N,Waldraff D,Dickinson E,Eirich K,Schindler D,Hagen M,Jerry DJ,Wiesmüller L

    更新日期:2013-11-28 00:00:00

  • Phosphorylation of integrin in differentiating ts-Rous sarcoma virus-infected myogenic cells.

    abstract::The differentiation of primary myogenic cultures requires the attachment of the cells to an extracellular matrix substrate using an integrin family receptor. These integrin receptors can be phosphorylated on both their alpha and beta chains, and it has been postulated that phosphorylation regulates the receptor functi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Aneskievich BJ,Haimovich B,Boettiger D

    更新日期:1991-08-01 00:00:00

  • Four tumor suppressor loci on chromosome 9q in bladder cancer: evidence for two novel candidate regions at 9q22.3 and 9q31.

    abstract::The most common genetic alteration identified in transitional cell carcinoma (TCC) of the bladder is loss of heterozygosity (LOH) on chromosome 9. However, localization of tumor suppressor genes on 9q has been hampered by the low frequency of subchromosomal deletions. We have analysed 139 primary, initial low stage TC...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202277

    authors: Simoneau M,Aboulkassim TO,LaRue H,Rousseau F,Fradet Y

    更新日期:1999-01-07 00:00:00

  • Expression of alpha-catenin in alpha-catenin-deficient cells results in a reduced proliferation in three-dimensional multicellular spheroids but not in two-dimensional monolayer cultures.

    abstract::alpha-Catenin is an intracellular protein that associates with the carboxy-terminal region of cadherin, a cell adhesion molecule, via beta-catenin or gamma-catenin (plakoglobin). Linkage of cadherin to the cytoskeleton by catenins is required for full cadherin activity. Following transfection of an alpha-catenin-defic...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207423

    authors: Matsubara S,Ozawa M

    更新日期:2004-04-08 00:00:00

  • Snail is a repressor of RKIP transcription in metastatic prostate cancer cells.

    abstract::Diminished expression of the metastasis suppressor protein RKIP was previously reported in a number of cancers. The underlying mechanism remains unknown. Here, we show that the expression of RKIP negatively correlates with that of Snail zinc-transcriptional repressor, a key modulator of normal and neoplastic epithelia...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210860

    authors: Beach S,Tang H,Park S,Dhillon AS,Keller ET,Kolch W,Yeung KC

    更新日期:2008-04-03 00:00:00

  • An FGFR inhibitor converts the tumor promoting effect of TGF-β by the induction of fibroblast-associated genes of hepatoma cells.

    abstract::Tumors consistently mimic wound-generating chronic inflammation; however, why they do not heal like wounds with fibrotic scars remains unknown. The components of the tumor microenvironment, such as transforming growth factor β (TGF-β) and fibroblast growth factors (FGFs), may account for this phenomenon. Tumor formati...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.512

    authors: Zhang HR,Wang XD,Yang X,Chen D,Hao J,Cao R,Wu XZ

    更新日期:2017-07-06 00:00:00

  • Phosphorylation of p53 at serine 37 is important for transcriptional activity and regulation in response to DNA damage.

    abstract::The p53 tumor suppressor protein plays a critical role in mediating cellular response to stress. Upon DNA damage, post-translational modifications stabilize and activate this nuclear phosphoprotein. To determine the effect of phosphorylation site mutants in the context of the whole p53 protein, we performed reporter a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207005

    authors: Dohoney KM,Guillerm C,Whiteford C,Elbi C,Lambert PF,Hager GL,Brady JN

    更新日期:2004-01-08 00:00:00

  • Inhibition of androgen receptor activity by histone deacetylase 4 through receptor SUMOylation.

    abstract::The transcriptional activity of the androgen receptor (AR) is regulated by both ligand binding and post-translational modifications, including acetylation and small ubiquitin-like modifier (SUMO)ylation. Histone deacetylases (HDACs) are known to catalyze the removal of acetyl groups from both histones and non-histone ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.600

    authors: Yang Y,Tse AK,Li P,Ma Q,Xiang S,Nicosia SV,Seto E,Zhang X,Bai W

    更新日期:2011-05-12 00:00:00

  • Analysis of chimeric Gag-Arg/Abl molecules indicates a distinct negative regulatory role for the Arg C-terminal domain.

    abstract::Arg and c-Abl represent the mammalian member of the Abelson family of nonreceptor protein tyrosine kinases. The two proteins are composed of SH2, SH3, kinase and C-terminal domains. To examine Arg structure-function relationships we analysed a Gag-Arg fusion protein, analogous to the oncogenic Gag-Abl fusion protein o...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Mysliwiec T,Perego R,Kruh GD

    更新日期:1996-02-01 00:00:00

  • Autocrine interaction between TGF alpha and the EGF-receptor: quantitative requirements for induction of the malignant phenotype.

    abstract::Alterations affecting the epidermal growth factor (EGF)/transforming growth factor alpha (TGF alpha)-responsive mitogenic pathway are frequently detected in malignancies. In particular, the EGF-receptor (EGFR) molecule has been found overexpressed in a number of human tumors, and TGF alpha is produced by a large array...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Di Marco E,Pierce JH,Fleming TP,Kraus MH,Molloy CJ,Aaronson SA,Di Fiore PP

    更新日期:1989-07-01 00:00:00

  • Selective activation of Akt1 by mammalian target of rapamycin complex 2 regulates cancer cell migration, invasion, and metastasis.

    abstract::Mammalian target of rapamycin complex (mTORC) regulates a variety of cellular responses including proliferation, growth, differentiation and cell migration. In this study, we show that mammalian target of rapamycin complex 2 (mTORC2) regulates invasive cancer cell migration through selective activation of Akt1. Insuli...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.22

    authors: Kim EK,Yun SJ,Ha JM,Kim YW,Jin IH,Yun J,Shin HK,Song SH,Kim JH,Lee JS,Kim CD,Bae SS

    更新日期:2011-06-30 00:00:00

  • Control of MAPK signalling: from complexity to what really matters.

    abstract::Oncogenesis results from changes in kinetics or in abundance of proteins in signal transduction networks. Recently, it was shown that control of signalling cannot reside in a single gene product, and might well be dispersed over many components. Which of the reactions in these complex networks are most important, and ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208817

    authors: Hornberg JJ,Binder B,Bruggeman FJ,Schoeberl B,Heinrich R,Westerhoff HV

    更新日期:2005-08-25 00:00:00

  • Interferon γ is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells.

    abstract::B-cell CLL/lymphoma 6 (BCL6) exerts oncogenic effects in several human hematopoietic malignancies including chronic myeloid leukemia (CML), where BCL6 expression was shown to be essential for CML stem cell survival and self-renewal during imatinib mesylate (IM) treatment. As several lines of evidence suggest that inte...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.85

    authors: Madapura HS,Nagy N,Ujvari D,Kallas T,Kröhnke MCL,Amu S,Björkholm M,Stenke L,Mandal PK,McMurray JS,Keszei M,Westerberg LS,Cheng H,Xue F,Klein G,Klein E,Salamon D

    更新日期:2017-08-10 00:00:00

  • Frequent promoter hypermethylation of the O6-Methylguanine-DNA Methyltransferase (MGMT) gene in testicular cancer.

    abstract::Testicular germ cell tumours are classified into two major histological subgroups, seminomas and nonseminomas. All tumours display several recurrent chromosomal aberrations, but few target genes have been identified. Previous studies have shown that genome-wide hypermethylation of CpG islands is significantly more pre...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205978

    authors: Smith-Sørensen B,Lind GE,Skotheim RI,Fosså SD,Fodstad Ø,Stenwig AE,Jakobsen KS,Lothe RA

    更新日期:2002-12-12 00:00:00

  • Translational research in neuroendocrine tumors: pitfalls and opportunities.

    abstract::Interest in research on neuroendocrine tumors (NETs) has grown in the past 10 years, coinciding with improvements in our understanding of the molecular pathogenesis of NETs. In addition, NETs have become one of the most exciting settings for drug development. Two targeted agents for the management of advanced pancreat...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2016.316

    authors: Capdevila J,Casanovas O,Salazar R,Castellano D,Segura A,Fuster P,Aller J,García-Carbonero R,Jimenez-Fonseca P,Grande E,Castaño JP

    更新日期:2017-04-06 00:00:00

  • Shc3 affects human high-grade astrocytomas survival.

    abstract::A selective switch from expression of Shc1 gene to Shc3 occurs with maturation of neuronal precursors into postmitotic neurons. Previous studies showed that in the embryo, Shc1 is maximally expressed in dividing CNS stem cells while it is silenced in mature neurons, where it is replaced by Shc3. Under normal condition...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208708

    authors: Magrassi L,Conti L,Lanterna A,Zuccato C,Marchionni M,Cassini P,Arienta C,Cattaneo E

    更新日期:2005-08-04 00:00:00

  • Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions.

    abstract::The breast cancer susceptibility gene 1 (BRCA1) is mutated in approximately 50% of hereditary breast cancers, and its expression is decreased in 30-40% of sporadic breast cancers, suggesting a general role in breast cancer development. BRCA1 physically and functionally interacts with estrogen receptor-alpha (ERalpha) ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.405

    authors: Wen J,Li R,Lu Y,Shupnik MA

    更新日期:2009-01-29 00:00:00

  • 17beta-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo.

    abstract::Human WWOX gene encodes a proapoptotic WW domain-containing oxidoreductase WOX1 (also named WWOX, FOR2 or WWOXv1). Apoptotic and stress stimuli activate WOX1 via Tyr33 phosphorylation and nuclear translocation. WOX1 possesses a tetrad NSYK motif in the C-terminal short-chain alcohol dehydrogenase/reductase (SDR) domai...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208124

    authors: Chang NS,Schultz L,Hsu LJ,Lewis J,Su M,Sze CI

    更新日期:2005-01-20 00:00:00

  • Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions.

    abstract::To appreciate the involvement of known or potential susceptibility genes in sporadic breast tumors, we have searched for chromosomal deletions by studying loss of heterozygosity (LOH) at 43 microsatellite (CA)n markers from human chromosomes 10, 11 and 17, in 115 unselected consecutive samples of breast carcinoma with...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1200818

    authors: Kerangueven F,Eisinger F,Noguchi T,Allione F,Wargniez V,Eng C,Padberg G,Theillet C,Jacquemier J,Longy M,Sobol H,Birnbaum D

    更新日期:1997-01-23 00:00:00